I still haven't seen anything nor have I received a reply.
In the meantime, since there is so much discussion on the SAS (only trial participants or not), I emailed the TGA and asked specifically if non-trial subjects are eligible? Let's hope they answer and it's the same answer several got from IR. I'll keep you and everyone posted.
It will be nice to end this debate (it's almost as bad as the mid-year debate)! :)
Market Data 
Markets 
